Sonntag, 7. Mai 2017

Regulatory issues concerning CRISPR/Cas9-modified plants






The efficacy of CRISPR/Cas 9 technique to obtain precise genetic modifications makes it more difficult to identify a genetically modified plant one outside the lab and also to regulate this organism in the market. For a consumer and also a regulatory agency it would become nearly impossible to find out which organism was genetically modified and which does not. (Ledford, 2015) Furthermore, for many years modified organisms have been patented when they had an industrial use. With the new CRISPR/Cas 9 a regulation of the patenting is almost impossible due to many economic interests that are involved and the modification is hard to prove. (Rodriguez, 2016)



Although Switzerland has one of the most restrictiv laws concerning genetically modified organisms the current regulation in Switzerland does not cover the use of the CRISPR/Cas 9 sufficiently. Before a genetically modified organism can be put into circulation it must be researched and the confederation needs to grant authorisation. (BAFU, 2004) In my opinion, the biggest issue in the Swiss laws is the definition of a genetically modified organism: “Genetically modified organism means organisms in which the genetic material has been altered in a way that doesn’t occur under natural conditions by crossing or natural recombination” (Gene Technology Act, Art. 5, BAFU).



For that reason, organisms which have been modified with the CRISPR/Cas 9 system do not fall under that articles of law and would not be called GMOs according to the Swiss regulation. But how would you describe and regulate CRISPR/Cas9-modified organisms when the modification is hard to prove? I personally could not answer that question and time will show if anyone can.



If I had to create a forecast what the Swiss public would say about the use of CRISPR/Cas9-modified plants, the Swiss citizen would definitely reject a use of such a plant on the market. From my point of view, ignorance and fundamental miscommunication by the media would be the main problem. People are always afraid of new technologies and not without a reason. History has shown mankind many times that late results can always arrive and we as human beings do not learn anything from it. Even though the CRISPR/Cas 9 system is such a powerful tool, time is needed for a wide spread social acceptance.









References



Federal Office of Environment (BAFU) (2004) Federal Act of 21 March 2003 on Non-Human Gene Technology (Gene Technology Act, GTA) Retrieved on 7.5.2017 from https://www.admin.ch/opc/en/classified-compilation/19996136/index.html



Ledford, H. (2015) CRISPR, the disruptor. Nature 522: 20-24 found in Rodriguez, E. (2016) Ethical Issues inn Genome using Crispr/Cas9 System. J Clin Res Bioeth 7: 266



Rodriguez, E. (2016) Ethical Issues inn Genome using Crispr/Cas9 System. J Clin Res Bioeth 7: 266